NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Devices · USD

Avanos Medical Inc (AVNS) Stock Analysis

Avanos Medical Inc (AVNS) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

AVNS

$24.99

+$0.01 (+0.04%)

Last trade July 24, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AVNS with… →

AVNS Key Statistics

As of Jul 24, 2026
Trading
Open
$24.98
Previous Close
$24.98
Day's Range
24.98–25.00
52-Week Range
9.30–25.49
Volume
432.16K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.57
Valuation
Market Cap
$1.17B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
19.99
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.64
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.60
Financials (FY)
Revenue (FY)
$701.20M+1.95%
Net Income (FY)
−$72.90M
Profit marginThe share of revenue left as profit after all costs and taxes.
−10.39%
1-Year Return
+110.35%
Dividend and dates
Avg Volume
1.05M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AVNS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+122.53%
2025−29.46%
2024 (partial year)−3.75%

As of July 24, 2026.

AVNS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$701.20M−$72.90M−10.4%
2024$687.80M−$392.10M−57.0%
2023$673.30M−$61.80M−9.2%
2022$684.10M$50.50M7.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$701.20M$353.90M$15.40M−$72.90M−10.4%
2024$687.80M$381.30M$40.50M−$392.10M−57.0%
2023$673.30M$379.70M$4.20M−$61.80M−9.2%
2022$684.10M$394.20M$35.50M$50.50M7.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AVNS Valuation vs Medical Devices Median

Median of 151 stocks
MetricAVNSMedical Devices medianvs median
P/S ratio1.642.9845% below
Profit margin−10.39%−1.69%8.7 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Avanos Medical Inc (AVNS) at $1.17B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 2,287.

AVNS last closed at $24.99 on July 24, 2026. That is +$0.01 (+0.04%) against the previous close. Over the past 52 weeks the price has ranged from $9.30 to $25.49. The latest close sits 168.62% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $701.20M. Against the prior fiscal year total of $687.80M, that is a change of +1.95%. The same year closed with a net loss of $72.90M. Profit margin runs at −10.39%. That is 8.7 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −1.6.

Across the 4 fiscal years on file, revenue moves from $684.10M in 2022 to $701.20M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 19.99. The price-to-sales ratio is 1.64. On price-to-sales that is 45.05% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned +110.35%. The stored price history starts on December 19, 2024, and the total return since then is +51.09%. The reported beta is 1.57. Annualized volatility over the trailing 1 year is 77.15%.

Growth & Income

The record shows no dividend for AVNS.

So far in 2026 the price is +122.53%. The record holds one complete calendar year, 2025, which returned −29.46%.

Peer Comparison

Avanos Medical Inc (AVNS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Avanos Medical Inc AVNS $1.17B —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Avanos Medical Inc has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of July 24, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Visit website →